None listed
Conditions
Interventions
Drug : 12 weeks follow-up after single intraarticular injection of placebo (0.9% normal saline), trimamcinolone acetonide 20mg (low dose steroid), or trimamcinolone acetonide 40mg (high dose steroid).
Sponsors
Ajou University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Age, 20 to 70 years old (2) pain and stiffness in predominantly one shoulder for =1 months; restriction of passive motion of greater than 30° in two or more planes of movement, measured to onset of pain with a long-arm goniometer
Exclusion criteria
Exclusion criteria: (1) severe pain at rest, defined as 7 out of 10 on a visual analogue scale (2) systemic inflammatory joint disease (including rheumatoid arthritis) (3) suspicious of osteoarthritis of the shoulder or fracture (4) suspicious of a complete or full thickness rotator cuff tear (weakness of arm elevation, a positive ‘‘drop arm sign’’, a high riding humerus visible on x ray examination of the shoulder, or demonstration on ultrasound) (5) current antiplatelet treatment including aspirin or warfarin (6) allergy to local anaesthetic (7) uncontrolled serum glucose level in diabetes patient (8) previous history of shoulder surgery (9) previous history of intraarticular injection (10) pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall shoulder pain using a horizotal Likert scale, labelled ‘‘no pain’’ at the left (0) and ‘‘maximum imaginable pain’’ at the right (10) | — |
Secondary
| Measure | Time frame |
|---|---|
| Passive range of motion of shoulder;Shoulder pain and disability index (SPADI) | — |
Countries
Korea, Republic of
Contacts
Public ContactSeung-Hyun Yoon
Ajou University Hospital
Outcome results
None listed